Institutional investors purchased a net $512.2 thousand shares of STJ during the quarter ended March 2013, and now own 92.40% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
| Mutual fund holders | 52.27% |
| Other institutional | 40.13% |
| Individual stakeholders | 2.56% |